Structure Therapeutics Inc.
GPCR
$21.76
$3.2317.43%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 23.94% | 53.40% | 71.32% | 74.03% | 138.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 51.84% | 75.31% | 28.20% | 62.93% | 139.23% |
| Operating Income | -51.84% | -75.31% | -28.20% | -62.93% | -139.23% |
| Income Before Tax | -46.46% | -44.46% | -12.17% | -44.89% | -105.85% |
| Income Tax Expenses | 143.59% | -77.28% | -55.08% | 16.00% | -73.33% |
| Earnings from Continuing Operations | -48.88% | -42.39% | -11.83% | -44.85% | -106.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.88% | -42.39% | -11.83% | -44.85% | -106.34% |
| EBIT | -51.84% | -75.31% | -28.20% | -62.93% | -139.23% |
| EBITDA | -51.42% | -74.81% | -27.67% | -62.38% | -139.87% |
| EPS Basic | -20.38% | 4.64% | 13.42% | 25.71% | 85.07% |
| Normalized Basic EPS | 8.68% | 3.24% | 13.16% | 25.70% | 86.83% |
| EPS Diluted | -20.38% | 4.64% | 13.42% | 25.71% | 85.07% |
| Normalized Diluted EPS | 8.68% | 3.24% | 13.16% | 25.70% | 86.83% |
| Average Basic Shares Outstanding | 23.68% | 49.31% | 29.17% | 94.98% | 1,282.33% |
| Average Diluted Shares Outstanding | 23.68% | 49.31% | 29.17% | 94.98% | 1,282.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |